Press Release (ePRNews.com) - MOSCOW, Russian Federation - Oct 26, 2016 - The solution was developed for safety monitoring of medicinal products. Since 2016, marketing authorization holders in Russia are obliged to collect safety information about drug products and other data to reduce health risks. Meeting these obligations without special software is a very hard and time-consuming task.
Data MATRIX Pharmacovigilance module allows to enter all the necessary information and to work with it. The application stores and manages data, helps to identify and analyze risks with the use of recommended statistical data processing methods. The solution also allows generating reports compliant with regulatory requirements.
Multi-level data organization provides qualitative and comfortable work with safety information.
In the future, we plan to maximize the module’s integration with MATRIX EDC and MATRIX CTMS to import both clinical and post-marketing safety data about medicinal products.
We continuously strive to meet the demands of our customers by creating user-friendly, highly intuitive and functional applications aimed to satisfy the needs of every particular project while automating processes and optimizing resource costs. All Data MATRIX (https://www.dm-matrix.com/) applications, including Pharmacovigilance (https://www.dm-matrix.com/services/solutions/pharmacovigilance/) are developed and undergo regular updates in accordance with industry and regulatory requirements. Source :